Myeloid cell-derived creatine in the hypoxic niche promotes glioblastoma growth
Aida Rashidi, Leah K. Billingham, Andrew Zolp, Tzu-Yi Chia, Caylee Silvers, Joshua L. Katz, Cheol Park, Suzi Delay, Lauren Boland, Yuheng Geng, Steven M. Markwell, Crismita Dmello, Víctor A. Arrieta, Kaylee Zilinger, Irene M. Jacob, Aurora Lopez‐Rosas, David Hou, Brandyn Castro, Alicia Steffens, Kathleen McCortney, Jordain Walshon, Mariah S. Flowers, Hanchen Lin, Hanxiang Wang, Junfei Zhao, Adam M. Sonabend, Peng Zhang, Atique U. Ahmed, Daniel J. Brat, Dieter Henrik Heiland, Catalina Lee-Chang, Maciej S. Lesniak, Navdeep S. Chandel, Jason Miska
Topics & Concepts
CreatineBiologyMyeloidHypoxia (environmental)Cancer researchPhenotypeTumor hypoxiaInternal medicineEndocrinologyMedicineBiochemistryRadiation therapyChemistryGeneOrganic chemistryOxygenCancer, Hypoxia, and MetabolismMetabolomics and Mass Spectrometry StudiesAdipose Tissue and Metabolism